EDITAS MEDICINE, INC. General and Administrative Expense
EDITAS MEDICINE, INC. (EDIT) reported General and Administrative Expense of $11.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-05
- EDITAS MEDICINE, INC. general and administrative expense for the quarter ending 2026-06-30 was $11.60M, a 9.77% decline year-over-year.
- EDITAS MEDICINE, INC. general and administrative expense for the quarter ending 2026-03-31 was $10.23M, a 23.48% decline year-over-year.
- EDITAS MEDICINE, INC. general and administrative expense for the quarter ending 2025-12-31 was $11.35M, a 30.58% decline year-over-year.
- EDITAS MEDICINE, INC. general and administrative expense for the quarter ending 2025-09-30 was $12.32M, a 31.91% decline year-over-year.
- EDITAS MEDICINE, INC. general and administrative expense for fiscal 2025 was $49.90M, a 30.68% decline from fiscal 2024.
- EDITAS MEDICINE, INC. general and administrative expense for fiscal 2024 was $71.99M, a 3.35% increase from fiscal 2023.
- EDITAS MEDICINE, INC. general and administrative expense for fiscal 2023 was $69.65M, a 1.49% decline from fiscal 2022.
- EDITAS MEDICINE, INC. general and administrative expense for fiscal 2022 was $70.70M, a 7.19% decline from fiscal 2021.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.60M 10-Q · filed 2026-08-05 | $21.84M 10-Q · filed 2026-08-05 | $33.19M derived: sum of 3 quarters · filed 2026-08-05 | $45.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $10.23M 10-Q · filed 2026-05-05 | $21.59M derived: sum of 2 quarters · filed 2026-05-05 | $33.90M derived: sum of 3 quarters · filed 2026-05-05 | $46.76M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $23.67M derived: sum of 2 quarters · filed 2026-03-09 | $36.53M derived: sum of 3 quarters · filed 2026-08-05 | $49.90M 10-K · filed 2026-03-09 |
| 2025-09-30 | $12.32M 10-Q · filed 2025-11-10 | $25.18M derived: sum of 2 quarters · filed 2026-08-05 | $38.55M 10-Q · filed 2025-11-10 | $54.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $12.86M 10-Q · filed 2026-08-05 | $26.23M 10-Q · filed 2026-08-05 | $42.59M derived: sum of 3 quarters · filed 2026-08-05 | $60.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.38M 10-Q · filed 2026-05-05 | $29.73M derived: sum of 2 quarters · filed 2026-05-05 | $47.82M derived: sum of 3 quarters · filed 2026-05-05 | $66.02M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $16.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $34.44M derived: sum of 2 quarters · filed 2026-03-09 | $52.65M derived: sum of 3 quarters · filed 2026-03-09 | $71.99M 10-K · filed 2026-03-09 |
| 2024-09-30 | $18.09M 10-Q · filed 2025-11-10 | $36.29M derived: sum of 2 quarters · filed 2025-11-10 | $55.63M 10-Q · filed 2025-11-10 | $70.09M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $18.21M 10-Q · filed 2025-08-12 | $37.55M 10-Q · filed 2025-08-12 | $52.00M derived: sum of 3 quarters · filed 2025-08-12 | $66.99M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $19.34M 10-Q · filed 2025-05-12 | $33.79M derived: sum of 2 quarters · filed 2025-05-12 | $48.78M derived: sum of 3 quarters · filed 2025-05-12 | $65.98M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $29.44M derived: sum of 2 quarters · filed 2025-03-05 | $46.64M derived: sum of 3 quarters · filed 2025-03-05 | $69.65M 10-K · filed 2025-03-05 |
| 2023-09-30 | $14.99M 10-Q · filed 2024-11-04 | $32.19M derived: sum of 2 quarters · filed 2024-11-04 | $55.20M 10-Q · filed 2024-11-04 | $73.18M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $17.20M 10-Q · filed 2024-08-07 | $40.21M 10-Q · filed 2024-08-07 | $58.19M derived: sum of 3 quarters · filed 2025-03-05 | $74.43M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $23.01M 10-Q · filed 2024-05-08 | $40.99M derived: sum of 2 quarters · filed 2025-03-05 | $57.23M derived: sum of 3 quarters · filed 2025-03-05 | $74.17M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $17.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $34.22M derived: sum of 2 quarters · filed 2025-03-05 | $51.16M derived: sum of 3 quarters · filed 2025-03-05 | $70.70M 10-K · filed 2025-03-05 |
| 2022-09-30 | $16.24M 10-Q · filed 2023-11-03 | $33.17M derived: sum of 2 quarters · filed 2023-11-03 | $52.72M 10-Q · filed 2023-11-03 | $69.24M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $16.94M 10-Q · filed 2023-08-02 | $36.48M 10-Q · filed 2023-08-02 | $53.01M derived: sum of 3 quarters · filed 2024-02-28 | $69.19M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $19.55M 10-Q · filed 2023-05-05 | $36.07M derived: sum of 2 quarters · filed 2024-02-28 | $52.26M derived: sum of 3 quarters · filed 2024-02-28 | $74.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $16.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $32.71M derived: sum of 2 quarters · filed 2024-02-28 | $54.74M derived: sum of 3 quarters · filed 2024-02-28 | $76.18M 10-K · filed 2024-02-28 |
| 2021-09-30 | $16.18M 10-Q · filed 2022-11-02 | $38.21M derived: sum of 2 quarters · filed 2022-11-02 | $59.66M 10-Q · filed 2022-11-02 | $75.44M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $22.03M 10-Q · filed 2022-08-03 | $43.47M 10-Q · filed 2022-08-03 | $59.26M derived: sum of 3 quarters · filed 2023-02-22 | $79.19M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $21.45M 10-Q · filed 2022-05-04 | $37.23M derived: sum of 2 quarters · filed 2023-02-22 | $57.17M derived: sum of 3 quarters · filed 2023-02-22 | $71.25M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $35.72M derived: sum of 2 quarters · filed 2023-02-22 | $49.80M derived: sum of 3 quarters · filed 2023-02-22 | $67.58M 10-K · filed 2023-02-22 |
| 2020-09-30 | $19.94M 10-Q · filed 2021-11-09 | $34.02M derived: sum of 2 quarters · filed 2021-11-09 | $51.79M 10-Q · filed 2021-11-09 | $68.70M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $14.08M 10-Q · filed 2021-08-05 | $31.85M 10-Q · filed 2021-08-05 | $48.77M derived: sum of 3 quarters · filed 2022-02-24 | $64.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $17.77M 10-Q · filed 2021-05-06 | $34.69M derived: sum of 2 quarters · filed 2022-02-24 | $50.42M derived: sum of 3 quarters · filed 2022-02-24 | $64.83M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $16.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $32.65M derived: sum of 2 quarters · filed 2022-02-24 | $47.06M derived: sum of 3 quarters · filed 2022-02-24 | $64.56M 10-K · filed 2022-02-24 |
| 2019-09-30 | $15.73M 10-Q · filed 2020-11-06 | $30.15M derived: sum of 2 quarters · filed 2020-11-06 | $47.64M 10-Q · filed 2020-11-06 | $60.81M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $14.41M 10-Q · filed 2020-08-07 | $31.90M 10-Q · filed 2020-08-07 | $45.08M derived: sum of 3 quarters · filed 2021-02-26 | $58.41M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $17.49M 10-Q · filed 2020-05-08 | $30.67M derived: sum of 2 quarters · filed 2021-02-26 | $44.00M derived: sum of 3 quarters · filed 2021-02-26 | $58.31M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $26.51M derived: sum of 2 quarters · filed 2021-02-26 | $40.82M derived: sum of 3 quarters · filed 2021-02-26 | $55.01M 10-K · filed 2021-02-26 |
| 2018-09-30 | $13.33M 10-Q · filed 2019-11-12 | $27.64M derived: sum of 2 quarters · filed 2019-11-12 | $41.83M 10-Q · filed 2019-11-12 | $55.52M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $14.31M 10-Q · filed 2019-08-07 | $28.50M 10-Q · filed 2019-08-07 | $42.18M derived: sum of 3 quarters · filed 2020-02-26 | $54.82M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $14.19M 10-Q · filed 2019-05-08 | $27.87M derived: sum of 2 quarters · filed 2020-02-26 | $40.51M derived: sum of 3 quarters · filed 2020-02-26 | $52.40M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $13.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $26.32M derived: sum of 2 quarters · filed 2020-02-26 | $38.21M derived: sum of 3 quarters · filed 2020-02-26 | $50.50M 10-K · filed 2020-02-26 |
| 2017-09-30 | $12.63M 10-Q · filed 2018-11-08 | $24.53M derived: sum of 2 quarters · filed 2018-11-08 | $36.82M 10-Q · filed 2018-11-08 | $49.86M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $11.89M 10-Q · filed 2018-08-07 | $24.18M 10-Q · filed 2018-08-07 | $37.23M derived: sum of 3 quarters · filed 2019-03-01 | $48.52M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $12.29M 10-Q · filed 2018-05-04 | $25.34M derived: sum of 2 quarters · filed 2019-03-01 | $36.63M derived: sum of 3 quarters · filed 2019-03-01 | $48.79M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $13.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $24.34M derived: sum of 2 quarters · filed 2019-03-01 | $36.50M derived: sum of 3 quarters · filed 2019-03-01 | $46.26M 10-K · filed 2019-03-01 |
| 2016-09-30 | $11.29M 10-Q · filed 2017-11-08 | $23.45M derived: sum of 2 quarters · filed 2017-11-08 | $33.22M 10-Q · filed 2017-11-08 | $40.55M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $12.16M 10-Q · filed 2017-08-09 | $21.92M 10-Q · filed 2017-08-09 | $29.26M derived: sum of 3 quarters · filed 2018-03-08 | $33.46M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $9.76M 10-Q · filed 2017-05-15 | $17.10M derived: sum of 2 quarters · filed 2018-03-08 | $21.30M derived: sum of 3 quarters · filed 2018-03-08 | $24.58M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $11.54M derived: sum of 2 quarters · filed 2018-03-08 | $14.82M derived: sum of 3 quarters · filed 2018-03-08 | $18.09M 10-K · filed 2018-03-08 |
| 2015-09-30 | $4.20M 10-Q · filed 2016-11-09 | $7.48M derived: sum of 2 quarters · filed 2016-11-09 | $10.76M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $3.28M 10-Q · filed 2016-08-10 | $6.55M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $3.27M 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | $7.65M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |